Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa
NCT04727268 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2021-10-04
Summary
This study will collect genetic and clinical information of junctional epidermolysis bullosa (JEB) patients. Computer analysis will be performed on genetic mutations found in these patients and this will be correlated with their clinical characteristics.
Conditions
- Junctional Epidermolysis Bullosa
- Laryngo Onycho Cutaneous Syndrome
Interventions
- OTHER
-
No intervention
No interventions present in this study.
Sponsors & Collaborators
-
Dystrophic Epidermolysis Bullosa Research Association (DEBRA)
collaborator UNKNOWN -
University of Birmingham
collaborator OTHER -
University Hospital Birmingham NHS Foundation Trust
lead OTHER
Eligibility
- Min Age
- 0 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-27
- Primary Completion
- 2021-12-30
- Completion
- 2021-12-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
NCT05529134 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Genetic Variants in Linear Localized Scleroderma
NCT02222038 ·Status: COMPLETED ·Phase: NA
-
Computational Drug Repurposing for All EBS Cases
NCT03269474 ·Status: RECRUITING
-
Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT01019148 ·Status: RECRUITING
-
Impact of Complex Care Training of Hereditary Epidermolysis Bullosa on Caregiver Burden (FIREB)
NCT05248503 ·Status: COMPLETED
-
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
NCT04213261 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro
NCT06177353 ·Status: RECRUITING
-
Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa
NCT03158662 ·Status: COMPLETED
-
Pilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEB
NCT02004600 ·Status: WITHDRAWN ·Phase: NA
-
Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
NCT00533572 ·Status: TERMINATED
-
Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa
NCT04285294 ·Status: UNKNOWN
-
Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT01874769 ·Status: COMPLETED
-
Gene First Approach to Connective Tissue Disease
NCT04664478 ·Status: COMPLETED
-
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT02810951 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Dentatorubral-pallidoluysian Atrophy Natural History and Biomarkers Study
NCT06273150 ·Status: RECRUITING
-
A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa
NCT04213703 ·Status: WITHDRAWN
-
Study of Scaling Disorders and Other Inherited Skin Diseases
NCT00001292 ·Status: COMPLETED
-
A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
NCT06563414 ·Status: RECRUITING
-
Prevalence of Onychodystrophy in Patients With Chronic Venous Disease of the Lower Limbs
NCT02731222 ·Status: COMPLETED
-
Artificial Intelligence Patient App for RDEB SCCs
NCT05843994 ·Status: ACTIVE_NOT_RECRUITING
-
Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
NCT05732987 ·Status: RECRUITING
-
Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT00904163 ·Status: COMPLETED
-
Addressing Inequity in Dermatology
NCT06056648 ·Status: RECRUITING
-
Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT03392909 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)
NCT04214002 ·Status: WITHDRAWN